Evidence map›Paper›PMID 39071072›Full record

ArticleCureus2024

Ceftaroline-Induced Thrombocytopenia: A Case Report.

Diego Ortiz-Mendiguren, Ian Crespo-Orta, Mark Miranda-Márquez, Nicole Rivera-Bobe, Glorivette San Vicente-Morales

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Diego Ortiz-MendigurenInternal Medicine, Veterans Affairs Caribbean Healthcare System, San Juan, PRI.
Ian Crespo-OrtaInternal Medicine, Veterans Affairs Caribbean Healthcare System, San Juan, PRI.
Mark Miranda-MárquezHematology/Oncology, Veterans Affairs Caribbean Healthcare System, San Juan, PRI.
Nicole Rivera-BobeAllergy and Immunology, Veterans Affairs Caribbean Healthcare System, San Juan, PRI.
Glorivette San Vicente-MoralesHematology/Oncology, Veterans Affairs Caribbean Healthcare System, San Juan, PRI.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug-induced thrombocytopenia is a rare but significant adverse effect of certain medications, with the potential for severe bleeding, thrombosis, and death. This report discusses a rare case of severe thrombocytopenia induced by ceftaroline in a 69-year-old male with a history of atrial fibrillation on rivaroxaban and allergies to amoxicillin and sulfa drugs. Following the initiation of ceftaroline for left lower extremity purulent cellulitis, his platelet count dropped from 204,000 to 4,000 x 10³/μL within a day. Given the low platelet levels, anticoagulation therapy, and bleeding risk, immediate interventions and prompt recognition prevented major complications, highlighting the importance of recognizing drug-induced thrombocytopenia in clinical practice.

Indexed as

abruptantibioticceftarolinedrugdrug-induced immune thrombocytopeniaimmuneinducedseverethrombocytopenia

Identifiers

PMID39071072
PMCPMC11282444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.